Ecolab Q3 EPS Miss Estimates; Warns On Macroeconomic Uncertainties

  • Ecolab Inc ECL reported third-quarter FY22 sales growth of 10% year-on-year to $3.669 billion, marginally beating the consensus of $3.66 billion.
  • Sales from Global Industrial rose 16%, Global Institutional & Specialty climbed 12%, Global Healthcare & Life Sciences grew 34% Y/Y in fixed currency.
  • Adjusted EPS of $1.30 missed the analyst consensus of $1.31.
  • Selling, general and administrative expenses rose 5% Y/Y. The operating margin was 13.2%, and operating income for the quarter rose 4% to $483 million.
  • The company held $112.9 million in cash and equivalents as of September 30, 2022.
  • Ecolab said it is preparing for a more challenging macroeconomic environment, especially in Europe, with high delivered product costs and unfavorable currency translation impacts that are expected to persist well into 2023.
  • ECL expects to deliver a continued strong acceleration in Q4 operating income growth. It sees Q4 adjusted EPS approaching last year's $1.28, below the consensus of $1.49.
  • Price Action: ECL shares are trading lower by 8.79% at $143.35 on the last check Tuesday.
  • Photo Via Wikimedia Commons
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!